TNFSF10 and neoplasm: This combination therapy also resultedin significant tumor growth inhibition (Figures F and S4) andprolonged survival (Figure G) compared to those of monotherapies (GOx-LGP or TRAIL-LGPalone) or control groups, highlighting the potent synergy betweenGOx-induced metabolic stress and TRAIL-mediated apoptosis.